Ucb Biosciences, Inc.
Clinical trials sponsored by Ucb Biosciences, Inc., explained in plain language.
-
Hope for rare muscle disease: experimental treatment trial advances
Disease control OngoingThis study continues testing an experimental combination therapy (doxecitine and doxribtimine) in people with thymidine kinase 2 deficiency, a rare genetic disorder that causes muscle weakness and breathing problems. The research aims to see if long-term treatment is safe and whe…
Phase: PHASE2 • Sponsor: UCB BIOSCIENCES, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Hope for tots: testing seizure drug in infants with rare, severe epilepsy
Disease control OngoingThis study is testing the safety and effects of a medication called fenfluramine in very young children (1 to under 2 years old) who have Dravet syndrome, a severe form of epilepsy. The main goal is to see if the drug is safe for their hearts and bodies, while also checking if it…
Phase: PHASE3 • Sponsor: UCB BIOSCIENCES, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC